DoD Tuberous Sclerosis Complex, Idea Development Award
ID: 353645Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353645
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the Tuberous Sclerosis Complex (TSC) Idea Development Award, a federal grant aimed at supporting innovative research that addresses high-impact findings in TSC. This opportunity encourages applications that propose conceptually innovative research with a strong scientific rationale and preliminary data, focusing on areas such as neuropsychiatric disorders, tumor prevention, and epilepsy treatments associated with TSC. With an estimated total program funding of $2.4 million and the expectation of awarding three grants, the application process includes a pre-application due by June 12, 2024, followed by a full application due by August 1, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524TSCRPIDA_GG.pdf
    The Department of Defense's FY24 Tuberous Sclerosis Complex Research Program seeks applications for the Idea Development Award aimed at high-impact research relevant to Service Members, Veterans, and the public. The application process involves a two-step submission, starting with a pre-application due by June 12, 2024, followed by a full application due by August 1, 2024. This funding opportunity, with $8 million appropriated for FY24, emphasizes research that innovatively addresses areas like neuropsychiatric disorders associated with Tuberous Sclerosis Complex (TSC), tumor prevention, and epilepsy treatments. Eligible applicants include independent investigators, both established and those new to TSC research, with a budget cap of $500,000 for a maximum performance period of three years. The review process is two-tiered, involving peer and programmatic assessments, with a focus on impact, innovation, and feasibility of the proposed studies. The announcement outlines strict submission guidelines and eligibility criteria to ensure compliance with funding regulations while promoting advancements in TSC research.
    Similar Opportunities
    DoD Multiple Sclerosis, Clinical Trial Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Multiple Sclerosis Clinical Trial Award to support clinical trials aimed at improving treatment and management of multiple sclerosis (MS). This funding opportunity encourages innovative trials that may include new pharmacologic agents, devices, or emerging technologies, with a total estimated program funding of $8 million and the expectation of awarding three grants. Eligible applicants include unrestricted entities, and the funding levels are set at a maximum of $2 million for small-scale trials and $4 million for larger-scale studies, with a pre-application deadline of June 10, 2024, and a full application deadline of October 7, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    CDMRP Neurofibromatosis Synergistic Idea Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the Neurofibromatosis Synergistic Idea Award, a federal grant aimed at fostering collaborative research projects focused on neurofibromatosis (NF). This award encourages innovative, multidisciplinary approaches involving two or three Principal Investigators (PIs) to address significant challenges in NF research, with an emphasis on developing new therapeutics and enhancing research capacity. With an estimated total program funding of $6.4 million for FY24 and the expectation of awarding two grants, interested applicants must submit a pre-application letter of intent by September 12, 2024, followed by full applications due by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Rare Cancers, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the Congressionally Directed Medical Research Programs (CDMRP), is offering the Fiscal Year 2024 Rare Cancers Idea Development Award to support innovative research aimed at advancing the understanding and treatment of rare cancers. This grant opportunity encourages proposals that focus on understanding molecular pathways, developing tumor-specific models, or identifying novel therapies, with an emphasis on research that can significantly impact patient outcomes. The total funding available for this program is approximately $17.5 million, with individual awards capped at $350,000 over a three-year period, and applications are due in two stages: a pre-application by June 17, 2024, and a full application by September 23, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    CDMRP Neurofibromatosis Exploration-Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Neurofibromatosis Exploration-Hypothesis Development Award, aimed at funding innovative research related to neurofibromatosis (NF). This grant supports the exploration of high-risk, high-gain concepts to enhance understanding and treatment of NF1, NF2, and schwannomatosis, with an estimated total program funding of $1.12 million and the expectation to fund approximately seven projects. The application process is two-tiered, requiring pre-applications by September 12, 2024, and full applications by October 3, 2024, with a focus on innovation, research feasibility, and impact on NF research and patient care. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Reconstructive Transplant, Idea Discovery Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Reconstructive Transplant Idea Discovery Award, a federal grant aimed at supporting innovative and high-risk research in reconstructive transplant and immunotherapy. This grant seeks to generate robust data that can lead to new scientific investigations, particularly focusing on enhancing immunosuppression techniques and advancing tissue preservation strategies relevant to military personnel and veterans. With an estimated total program funding of $2.5 million, the award will provide up to $500,000 for each selected project over a two-year period, contingent upon the availability of federal funds and the merit of applications. Interested applicants must submit a pre-application by August 7, 2024, followed by a full application due by October 23, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Tick-Borne Disease, Idea Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity, is offering the FY24 Tick-Borne Disease Idea Development Award, aimed at funding innovative research focused on tick-borne diseases, particularly Lyme disease. This grant seeks to support conceptually innovative projects that challenge existing paradigms and propose novel methodologies to reduce the public health burden associated with these diseases, ultimately improving patient care for military Service Members, Veterans, and the American public. With an estimated total program funding of $3.64 million, the program anticipates awarding approximately five grants, with applications due in two phases: pre-applications by June 26, 2024, and full applications by October 3, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Tick-Borne Disease Therapeutic/Diagnostic Research Award to support innovative research aimed at addressing tick-borne diseases, particularly Lyme disease. This grant seeks applications focused on therapeutic and diagnostic development with demonstrated feasibility, emphasizing projects that can improve patient care and quality of life for military Service Members, Veterans, and the general public. With an estimated total program funding of $2,656,000 and the expectation of awarding two grants, applicants must submit a pre-application through eBRAP by October 3, 2024, followed by a full application via Grants.gov upon invitation. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DoD Traumatic Brain Injury and Psychological Health, Translational Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Traumatic Brain Injury and Psychological Health Translational Research Award (TRA) to advance research aimed at improving care for psychological health conditions and traumatic brain injuries (TBI). This grant opportunity focuses on hypothesis-driven research that seeks to develop novel healthcare products, clinical practices, and technologies, with an emphasis on translational research that leads to practical applications in clinical settings. With an estimated total program funding of $17.05 million, the program anticipates awarding approximately 14 grants, with funding caps of $500,000 for smaller projects and $1 million for larger, more complex research initiatives. Interested applicants must submit a pre-application by June 27, 2024, and full applications by October 3, 2024; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org.
    DoD Multiple Sclerosis, Investigator-Initiated Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Fiscal Year 2024 Multiple Sclerosis Research Program (MSRP) via the Investigator-Initiated Research Award (IIRA). This grant aims to support innovative and high-impact research projects related to Multiple Sclerosis (MS), particularly those that can enhance patient care and quality of life, while excluding clinical trials. The program emphasizes research on central nervous system repair, disease progression correlates, symptom biology, and MS etiology, with a total funding pool of $6 million expected to yield approximately six awards, each up to $1 million over three years. Interested applicants must submit a pre-application by June 10, 2024, followed by a full application due by October 7, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    CDMRP Neurofibromatosis Early Investigator Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is offering the Neurofibromatosis Early Investigator Research Award, a federal grant aimed at supporting innovative research in neurofibromatosis (NF). This opportunity is specifically designed for early-stage investigators to develop research projects under the guidance of experienced mentors, focusing on understanding, diagnosing, and treating NF1, NF2, and schwannomatosis disorders. With a total estimated program funding of $640,000 and an expected two awards, each grant will not exceed $200,000 over a performance period of two years. Interested applicants must submit their proposals by October 3, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.